Document:

Exhibit 10.32

 

 

Consulting Agreement This consulting agreement
(the "Agreement") is made and entered on this day 11th day of February (the "Effective Date") by and between
Robert L. Hymers III (hereinafter referred to as the "Consultant") and Electromedical Technologies, Inc. (hereinafter
referred to as the "Client"). 1. Services The Consultant will provide strategic business and business services to the
Client, which may include: • Financial Consulting assistance with review of quarterly and annual filings with OTC Markets
and/or the SEC. • Corporate Governance and Compliance • Communication, review and coordination of document transfers
to auditors and attorneys. • Assistance with negotiation with contracts, financings, contracts and review and drafting of
corresponding agreements, all of which must be pre-approved by the Client's legal counsel. • Communication with SEC attorney,
auditors and outside accountants to complete resolutions and regulatory filings The scope of services will be subject to change
from time to time as agreed to between the Consultant and the Client. The Consultant will also provide briefings, updates and other
forms of communication to keep the Client informed regarding the progress of the work. The services will be rendered from the Consultant's
location and/or the Client's location subject to change as necessary to properly service the Client. The Consultant will perform
the services in a competent and professional manner. The Consultant will comply with applicable laws. The Consultant shall be responsible
for all taxes on any compensation. 2. Compensation and Reimbursement of Expenses The Client agrees to pay the Consultant a fixed
fee of one hundred fifty thousand (150,000) restricted common shares for the services provided. This fee shall cover 12 months
of services pursuant to Section 3 of this Agreement. The total amount owed per this agreement shall be deemed earned in full upon
the execution of this agreement (i.e., February I 2, 20 19) and shall not vest over time. For purposes of this agreement, the shares
are valued at $1.00 per share. The Consultant will maintain adequate documentation and records to support all costs invoiced to
the Client including receipts for travel related expenses however, such expenses

 

    

     

    

 

must be approved by the Client prior to being incurred
by Consultant. Payments made by the Client to the Consultant will not deduct any taxes and the Client will provide the Consultant
with IRS Form I 099 at the end of each calendar year. For purposes of issuing IRS Form I 099, the Consultant will provide a social
security number upon execution of his agreement. The shares of Common Stock provided for a compensation to Consultant may not be
sold or transferred unless: (i) such shares are sold pursuant to an effective registration statement under the Act or (ii) the
Consultant or its transfer agent shall have been furnished with an opinion of counsel (which opinion shall be in form, substance
and scope customary for opinions of counsel in comparable transactions) to the effect that the shares to be sold or transferred
may be sold or transferred pursuant to an exemption from such registration (iii) such shares are sold or transferred pursuant to
Rule I44 under the Act (or a successor rule) ("Rule I44"). The certificate for shares of Common Stock has not been so
included in an effective registration statement or that has not been sold pursuant to an effective registration statement or an
exemption that permits removal of the legend, shall bear a legend substantially in the following form, as appropriate: "NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF I933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT
BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN
A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE
144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT
OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES." 3. Term and Termination This agreement will commence on
the effective date set forth and continue for a period of twelve months from the effective date unless terminated earlier. Either
party may terminate this agreement at any time upon thirty-day (30) notification. The Client may at its option agree to renew,
extend and revise this agreement prior to its expiration.

 

    

     

    

 

4. Confidential Information Both parties acknowledge
that there is an exchange of confidential and proprietary information associated with this agreement. Confidential and proprietary
information may include documents, communications, plans, processes, formulations, data, know-how, financial information, techniques,
methods, customers, suppliers, partners, patents, trademarks, designs, and other forms of tangible or intangible artifacts owned
by the Client. Confidential and proprietary information does not include information within the public domain, information that
has been publicly known prior to the execution of this agreement, or information that the Consultant developed independent of any
confidential information. The Consultant will not divulge, disseminate, publish or otherwise disclose any information without the
prior consent of the Client. The Consultant will not use any information for purposes other than the performance of services described
in this agreement. The Client agrees to not disclose confidential information to the Consultant except to the extent that the Consultant
requires this information to fulfill the obligations within this agreement. If the Client has any concerns over the sharing of
sensitive information and requires additional control measures, the Consultant will establish secured means of information sharing
that are mutually agreeable to both parties. These control measures may include restricting who can copy, print, or change documents
during the course of the engagement. 5. Indemnification Not withstanding other provisions of this agreement, the Client shall indemnify,
defend and hold harmless the Consultant against claims, liabilities, damages, losses or other obligations, which may arise from
this agreement. 6. Relationship of Parties The parties agree that this agreement creates an independent contractor relationship,
not an employment relationship. Neither party is, nor shall claim to be, a legal agent, representative, partner, or employee of
the other, and neither shall have the right or authority to contract in the name of the other, nor shall it assume or create any
obligations, debts, accounts or liabilities for the other. 7. Role of the Consultant The Consultant will not make management decisions
on behalf of the Client. The role of the Consultant shall be advisory in nature with no perceived conflicts of interest prior to,
during or after the engagement with the Client. This role will also extend to any third parties that the Consultant may use during
the course of the engagement.

 

    

     

    

 

8. Reliance on Client Provide Information Regarding
any information or material that the Company furnishes to Consultant or any other entity in connection with this Agreement, the
Company acknowledges and confirms that (i) Consultant will use and rely on such information and material without independently
verifying the same, (ii) Consultant does not assume responsibility for the accuracy or completeness of any of the information or
material, (iii) Consultant will not make any appraisal, evaluation or independent determination regarding such information or material
or the Company and (iv) Consultants shall not have any liability in connection with such information or material. The Company represents
to Consultant that the information and material to be furnished by the Company, when delivered, will be true, complete and correct
in all material respects and will not contain any material misstatement of fact or omit to state any material fact necessary to
make the statements contained therein not misleading. The Company shall promptly notify Consultants if it learns of any material
inaccuracy or misstatement in, or material omission from, any information or material delivered to Consultant. 9. Quality Assurance
and Control In an effort to ensure that the Consultant provides high quality work, the Client will assign the CEO of the Client
company to review and approve the work of the Consultant. In the event that the Consultant uses a third party, the Consultant is
responsible for the quality of the work delivered by the third party. 10. Non-Agent of Client It is understood that Consultant
is not acting as agent or fiduciary of, and have no liabilities to, the equity holders of the Company or any other third party
in connection with this Agreement or any introductions, services or transactions hereunder, all of which liabilities are expressly
waived. 11. Clawback The compensation granted under this agreement are subject to the terms of the client's recoupment, clawback
or similar policy as it may be in effect from time to time, as well as any similar provisions of applicable law, any of which could
in certain circumstances (e.g. failure to perform throughout the term, gross negligence, violation of State laws, violation of
SEC regulations) require repayment or forfeiture of compensation or any shares of Common Stock or other cash or property received.
12. Governing Law This Agreement shall be governed by and interpreted in accordance with the laws of the state of Arizona applicable
to agreements negotiated, executed and to be performed in theExhibit
10.34

 

STOCK
PURCHASE AGREEMENT

 

This
Stock Purchase Agreement (“Agreement”) is made and entered into this 12th day of June, 2020, by
and between ElectroMedical Technologies, Inc., a Delaware corporation, with a business address of 16561 N 92nd Street Ste.
101, Scottsdale AZ 85260 (“Seller”), and ProActive Capital Partners, LP, a Delaware limited partnership, with
a business address of 150 E. 58th St. 20th Floor, New York, NY 10155 (“Purchaser”). Both Seller and Purchaser
are referred to individually as a “Party” and jointly as the “Parties.”

 

RECITALS

 

WHEREAS,
Seller is a clinical stage a bioelectronics manufacturing and marketing company selling medical devices for pain management. Its
Wellness Pro product received FDA clearance on July 6, 2007 (FDA K062616) as a Class II Medical Device, under the 510(K) clearance
process.

 

WHEREAS,
Seller filed Regulation “A” offering on September 20, 2017 on Form 1-A. Seller has filed all required Regulation
“A” reports to maintain its offering to date. Seller filed a Form S-1 registration statement on November 12,
2019, as amended. All of Seller’s disclosures filed with the Securities and Exchange Commission (“SEC”) are
available on Seller’s SEC Edgar web site (https://www.sec.gov/cgi-bin/browse-edgar?company=Electromedical&owner=exclude&action=getcompany).
The SEC has not made the Form S-1 effective as of the date hereof. As of the date of this Agreement, Seller is not subject
to the periodic reporting requirements of the 1934 Securities and Exchange Act and the regulations implementing the Exchange Act
SEC. Seller’s common stock is quoted on the OTC Markets, Inc. OTCQB tier tier electronic listing service trading under
the symbol “EMED”; and,

 

WHEREAS,
Seller desires to sell and Purchaser desires to purchase one hundred and forty two thousand, eight hundred and fifty-seven (142,857)
restricted shares of Seller’s common stock (“Purchased Shares”) at a price of thirty five cents ($0.35)
per share on the terms and subject to the conditions set forth in this Agreement.

 

AGREEMENT

 

NOW,
THEREFORE, in consideration of the mutual covenants and agreements contained in this Agreement, the sufficiency and adequacy of
which are acknowledged by the Parties, and in order to consummate the purchase and the sale of the Purchased Shares, it is hereby
agreed as follows:

 

1.
Purchase and Sale. Subject to the terms and conditions hereinafter set forth, at the Closing (defined below), Seller
shall sell, convey, transfer, and deliver to Purchaser a certificate or book entry confirmation of the issuance representing the
Purchased Shares, in consideration of the Purchase Price. The certificates representing the Purchased Shares shall be duly issued
in the name of the Purchaser. The Purchaser’s address is 150 E. 58th Street 20th Floor, New York, NY 10155. The
Purchaser’s tax identification number is 82-3535071.

 

    1

     

    

 

2.
Amount of Purchase Price. As total consideration for the purchase of the Purchased Shares, Purchaser shall pay to
Seller at the Closing the purchase price (“Purchase Price”) of fifty thousand dollars ($50,000.00). Seller’s
wire transfer instructions are: Electromedical Technologies, Bank of America, Routing number: 122101706, Account number: 457023402995.

 

3.
Representations and Warranties of Seller. Seller hereby warrants and represents:

 

(a) Seller
has all requisite power and authority to execute, deliver, and perform its obligations under this Agreement, and, when executed
and delivered by Seller, shall constitute the valid and binding obligation of Seller, enforceable against Seller in accordance
with its terms, subject to applicable bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium or other similar
laws affecting creditors’ rights and remedies generally, and subject, as to enforceability, to general principles of equity
(regardless of whether enforcement is sought in a proceeding at law or in equity);

 

(b) The
Purchased Shares have been duly authorized and, when conveyed by Seller to Purchaser at the Closing, all in accordance with the
terms of this Agreement, will be duly and validly issued, fully paid and non-assessable;

 

(c) Neither
the execution or delivery of this Agreement, nor any other documents required to be executed and delivered by Seller hereunder,
nor the consummation of the transaction contemplated hereby: (i) conflicts with or constitutes any violation or breach, or
gives any other person any rights (including, but not limited to, any legal rights to acceleration, termination, cancellation
or recession) under any document or agreement to which Seller is a party. Neither Seller’s entry into this Agreement, nor
Seller’s representations made in this Agreement, constitute a violation of any order or applicable law that Seller or to
which Seller’s assets are bound by or subject; and

 

(d) Seller
is a corporation validly existing and in good standing under the laws of the State of Delaware.

 

4.
Representations and Warranties of Purchaser. Purchaser hereby warrants and represents:

 

(a) Purchaser
has all requisite corporate power and authority to execute, deliver and perform its obligations under the Agreement, and the execution,
delivery, and performance by Purchaser of its obligations under the Agreement has been duly authorized by all requisite action
on the part of Purchaser and the Agreement, when executed and delivered by Purchaser, shall constitute the valid and binding obligation
of Purchaser, enforceable against Purchaser in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization,
fraudulent conveyance, moratorium or other similar laws affecting creditors’ rights and remedies generally, and subject,
as to enforceability, to general principles of equity (regardless of whether enforcement is sought in a proceeding at law or in
equity);

 

    2

     

    

 

(b) With
respect to the Purchased Shares acquired by Purchaser, Purchaser acknowledges that the Purchased Shares have not been registered
under the Securities Act of 1933, as amended (“Securities Act”) and are “Restricted Securities”
within the meaning of Rule 144 under the Securities Act. As such, the Purchased Shares may not be resold or transferred unless
Seller registers them in an SEC effective registration under Section 5 of the Securities Act, or has received an opinion
of counsel to Seller or any successor in interest thereto reasonably satisfactory to Seller that such resale or transfer is exempt
from the registration requirements of the Securities Act. Purchaser acknowledges that a no public market exists for the Purchased
Shares. Purchaser understands that no assurance can be given that such a trading market will further develop at any time, or,
if so developed, that it will continue;

 

(c) Purchaser
further acknowledges and agrees that its purchase of the Purchased Shares involves substantial risks. Purchaser: (i) either
alone or together with its representatives has such knowledge and experience in financial and business matters as to be capable
of evaluating the merits and risks of this investment, and make an informed decision to so invest, and has so evaluated the risks
and merits of such investment; (ii) has the ability to bear the economic risks of this investment for an indefinite period
and can afford a complete loss of such investment; (iii) understands the terms of, and the risks associated with the acquisition
of the Purchased Shares, including, without limitation, a lack of liquidity, price transparency or pricing availability and risks
associated with the industry in which Seller operates; (iv) has had the opportunity to review such disclosures regarding Sellers’s
business, financial condition and prospects as Purchaser has determined to be necessary in connection with the acquisition of
the Purchased Shares, including Seller’s public filings with the SEC, and the risk factors set forth therein, (v) is
an “accredited investor” as that term is defined in Regulation D promulgated under Securities Act; (vi) acknowledges
and agrees that the Purchased Shares are being offered and sold to it in reliance on specific exemptions from the registration
requirements of United States federal and state securities laws and that the Seller is relying upon the truth and accuracy of,
and such Purchaser’s compliance with, the representations, warranties, agreements, acknowledgments and understandings of
such Purchaser set forth herein in order to determine the availability of such exemptions and the eligibility of such Purchaser
to acquire the Purchased Shares; and (viii) understands and acknowledges that no United States federal or state agency or
any other government or governmental agency has passed on or made any recommendation or endorsement of the Securities or the fairness
or suitability of the investment in the Securities nor have such authorities passed upon or endorsed the merits of the offering
of the Securities.

 

(d) Purchaser
has received or has had full access to all the information Purchaser considers necessary or appropriate to make an informed investment
decision with respect to the Purchased Shares. Purchaser further has had an opportunity to ask questions of and receive answers
from the management of Seller regarding the Purchased Shares and to obtain additional information necessary to verify any information
furnished to Purchaser or to which Purchaser had access. Further, Purchaser has undertaken its own review of the business of Seller
and the wisdom of an investment in the Purchased Shares. Purchaser has had the opportunity to review all of the books, records
and all SEC filings of Seller, including all of Seller’s audited financial statements and disclosures that Seller has published
concerning its operations as a company reporting to the SEC;

 

    3

     

    

(e) Purchaser
is acquiring the Purchased Shares for its own account, and not with a view towards a public distribution of those Purchased Shares
as an underwriter for Seller, as that term is defined in the Securities Act. Purchaser acknowledges that it is not acquiring the
Purchased Shares as the result of any advertisement or solicitation, including any publicly issued or circulated newspaper, mail,
radio, television or other form of general advertising or solicitation in connection with the offer, sale and purchase from Seller
regarding Purchaser’s investment pursuant to this Agreement; and

 

(f) Purchaser
represents that Purchaser is familiar with the requirements of Rule 144 of the Securities Act, as presently in effect, and
understands the resale limitations imposed thereby. Purchaser understands that Seller is under no obligation to register any of
the Purchased Shares. Purchaser acknowledges that the certificates or book entry registry for the Purchased Shares, will be noted
as “Restricted” on the transfer agent’s ledger, or, if a certificate it issued, it will bear a legend substantially
in the form set forth below:

 

THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (“ACT”), OR UNDER
THE SECURITIES LAWS OF ANY OTHER JURISDICTION. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND
MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO
REGISTRATION OR EXEMPTION THEREFROM. PURCHASERS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF
THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME.

 

(g) Purchaser
is a corporation validly existing and in good standing under the laws of the State of Delaware.

 

5.
Representations, Warranties and Covenants of Seller and Purchaser.

 

(a) Seller
and Purchaser hereby represent and warrant that there has been no act or omission by Seller or Purchaser which would give rise
to any valid claim against any of the Parties for a brokerage commission, finder’s fee or other like payment in connection with
the transaction contemplated hereby, except for such claims as shall have been waived on or before the Closing Date;

 

(b) The
representations and warranties of Seller and Purchaser contained herein or in any document furnished pursuant hereto shall survive
the Closing of this transaction. Each Party acknowledges and agrees that, except as expressly set forth in this Agreement or any
closing document, no Party has made (and no Party is relying on) any representation or warranties of any nature, express or implied,
regarding anything relating to the transaction contemplated by this Agreement that are not contained herein; and

  

    4

     

    

 

(c) Purchaser
and Seller agree that each will, at any time and from time to time after the Closing, upon the request of the other Party, do,
execute, acknowledge and deliver, or will cause to be done, executed, acknowledged and delivered, all such further acts, assignments,
transfers, conveyances, powers of attorney and assurances as may be reasonably required from time to time in order to effectuate
the provisions and purposes of this Agreement.

 

6.
Conditions to Purchaser’s Obligations at Closing.

 

(a) Representations
and Warranties. Each of the representations and warranties of Seller shall be true and complete on and as of the Closing;
and

 

(b) Performance.
Seller shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that are
required to be performed or complied with by him on or before the Closing.

 

7.
Conditions to Seller’s Obligations at Closing.

 

(a) Representations
and Warranties. Each of the representations and warranties of Purchaser shall be true and complete on and as of the Closing;
and

 

(b) Payment
of Purchase Price. Purchaser shall have delivered to Seller the Purchase Price for the Purchased Shares to be acquired by
Purchaser pursuant to this Agreement.

 

8.
The Closing. Subject to the satisfaction or waiver of the conditions in this Agreement, the closing of the sale
to the Purchaser (“Closing”) shall take place on or before June 12, 2020 (or on such other date as is
mutually agreed upon by the Parties) (“Closing Date”). On the Closing Date, Purchaser shall pay the Purchase
Price to Seller by wire transfer of immediately available funds to Seller’s account at Bank of America, with wire instructions
provided in Section 2 above. Seller’s wire transfer instructions are: Electromedical Technologies, Bank of America,
Routing number: 122101706, Account number: 457023402995.

 

9.
General Provisions.

 

(a) Entire
Agreement. This Agreement constitutes the entire agreement between the parties and supersedes all prior agreements and understandings,
oral and written, between the Parties with respect to the subject matter hereof. This Agreement may not be amended except by a
written agreement signed by Purchaser and Seller.

 

(b) Sections
and Other Headings; Interpretation. The section and other headings contained in this Agreement are for reference purposes
only and shall not affect the meaning or interpretation of this Agreement. Whenever the context requires, words used in the singular
shall be construed to mean or include the plural and vice versa, and pronouns of any gender shall be deemed to include and designate
the masculine, feminine or neuter gender.

 

    5

     

    

 

(c) Governing
Law; Jurisdiction. This Agreement shall be deemed to be a contract made under the laws of the State of New York. This Agreement
and the construction, validity, enforcement, performance and interpretation of, or any dispute or claim arising out of or in relation
to, this Agreement (whether in contract, tort or otherwise) shall be construed in accordance with the laws of the State of New
York without giving effect to the rules of the State of New York governing the conflicts of laws (other than Section 5-1401
of the General Obligations Law of the State of New York). Each Party agrees that all legal proceedings concerning the interpretations,
enforcement and defense of this Agreement and the transactions herein contemplated (“Proceedings”) (whether
brought against a Party or its respective Affiliates, employees or agents) shall be commenced exclusively in the New York Courts.
Each Party hereto hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for the adjudication of any
dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably
waives, and agrees not to assert in any Proceeding, any claim that it is not personally subject to the jurisdiction of any New
York Court, or that such Proceeding has been commenced in an improper or inconvenient forum. Each Party hereby irrevocably waives
personal service of process and consents to process being served in any such Proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such Party at the address in effect for notices to it under
this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing
contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Each Party hereby
irrevocably, knowingly and voluntarily waives, to the fullest extent permitted by applicable law, any and all right to trial by
jury in any Proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. For purposes of this
Agreement, “New York Courts” means the state and federal courts sitting in the State of New York, City of New
York, Borough of Manhattan.

 

(d) Severability.
If any provision of this Agreement is determined by any court of competent jurisdiction to be invalid, illegal or unenforceable
in any respect, such provision will be enforced to the maximum extent possible given the intent of the Parties hereto. If such
clause or provision cannot be so enforced, such provision shall be stricken from this Agreement and the remainder of this Agreement
shall be enforced as if such invalid, illegal or unenforceable clause or provision had (to the extent not enforceable) never been
contained in this Agreement.

 

(e) Counterparts.
This Agreement may be executed in one or more counterparts, each of which will be deemed to be an original copy of this Agreement
and all of which, when taken together, will be deemed to constitute one and the same agreement. In the event that any signature
is delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create
a valid and binding obligation of the Party executing (or on whose behalf such signature is executed) with the same force and
effect as if such facsimile or “.pdf” signature page were an original thereof.

 

    6

     

    

 

(f) Waiver.
The rights and remedies of the Parties are cumulative and not alternative. Neither the failure nor any delay by any Party in exercising
any right, power, or privilege under this Agreement, or the documents referred to in this Agreement, will operate as a waiver
of such right, power, or privilege, and no single or partial exercise of any such right, power, or privilege will preclude any
other or further exercise of such right, power, or privilege or the exercise of any other right, power, or privilege.

 

(g) Successors
and Assigns. Except as otherwise provided in this Agreement, this Agreement, and the rights and obligations of the Parties
hereunder, will be binding upon and inure to the benefit of the Parties’ respective successors, assigns, heirs, executors,
administrators and legal representatives.

 

(h) Survival
of Warranties. The representations, warranties and covenants of Seller and Purchaser contained in or made pursuant to this
Agreement shall survive the execution and delivery of this Agreement and the Closing.

 

(i) Notices.
All notices, requests and demands (“Notice”) to or upon a Party, to be effective, shall be in writing and shall
be sent: (i) certified or registered mail, return receipt requested; (ii) by personal delivery against receipt; (iii) by
overnight courier; or (iv) by email and, unless otherwise expressly provided herein, and shall be deemed to have been validly
served, given, delivered and received: (x) on the date indicated on the receipt, when delivered by personal delivery against
receipt or by certified or registered mail; (y) one business day after deposit with an overnight courier; or (z) in
the case of email notice, when sent. Notices shall be addressed as follows:

 

To
Seller:

 

ElectroMedical
Technologies, Inc. 

Attention:
Matthew Wolfson, CEO 

16561
N 92nd Street Ste. 101 

Scottsdale
AZ 85260 

Email:
ceo@electromedtech.com

 

With
a copy to: 

Mailander
Law Office, Inc. 

4811
49th Street 

San
Diego, CA 92101 

tmailander@gmail.com

 

To
Purchaser:

 

ProActive
Capital Partners, LP

150
E. 58th Street 20th Floor

New
York, NY 10155

  

    7

     

    

 

Either
Party may change the address to which Notices shall be addressed by providing Notice of such change to the other Party in the
manner set forth in this subsection 9(i).

 

(j) Third
Parties. Nothing in this Agreement, express or implied, is intended to confer upon any person, other than the Parties hereto
and their successors and assigns, any rights or remedies under or by reason of this Agreement.

 

(k) Preparation
of Agreement. Seller prepared this Agreement solely on its behalf. Each Party to this Agreement acknowledges that: (i) the
Party had the advice of, or sufficient opportunity to obtain the advice of, legal counsel separate and independent of legal counsel
for any other Party hereto; (ii) the terms of the transactions contemplated by this Agreement are fair and reasonable to
such Party; and (iii) such Party has voluntarily entered into the transactions contemplated by this Agreement without duress
or coercion. Each Party further acknowledges that such Party was not represented by the legal counsel of the other Party in connection
with the transactions contemplated by this Agreement, nor was he or it under any belief or understanding that such legal counsel
was representing his or its interests. Each Party agrees that no conflict, omission or ambiguity in this Agreement, or the interpretation
thereof, shall be presumed, implied, or otherwise construed against the other Party on the basis that such Party was responsible
for drafting this Agreement.

 

IN
WITNESS WHEREOF, each of the undersigned has duly executed this Stock Purchase Agreement as of the date first written above.

 

SELLER  

   

ElectroMedical Technologies, Inc.  

a Delaware corporation  

 

	 	 
	By:  	 	 
	 	Printed Name: Matthew Wolfson	 
	 	Title: Chief Executive Officer	 

 

PURCHASER

 

ProActive
Capital Partners, LP 

a
Delware Limited Partnership

 

	By:  	 	 
	 	Printed Name: Jeff Ramson	 
	 	Title: Authorized Signatory	 

 

    8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00322-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00322-of-00352.parquet"}]]